MediElaj launches AI diagnostic kiosk pilot in Gurugram

MediElaj has launched a community pilot of its AI-based diagnostic kiosk in Gurugram, where the first unit has completed more than 200 diagnoses.

Installed in a neighbourhood community centre, the kiosk carries out a range of non-invasive checks through an automated interface. It has also conducted more than 350 non-invasive tests, including ECG and blood oxygen readings, as MediElaj seeks to bring basic diagnostic services closer to patients outside traditional clinical settings.

The company's approach centres on placing compact testing stations in neighbourhoods, workplaces, clinics and public health centres rather than relying only on hospitals and laboratories. It is targeting areas where access to screening is more limited and where travel costs and waiting times can deter routine checks.

MediElaj also runs a mobile app, which it says has passed 100,000 downloads. The app includes symptom assessment tools, wellness support and links to doctors on the platform.

Its network includes more than 150 empanelled doctors covering over 100 diseases, and the platform has logged more than 1,000 symptom evaluations.

Diagnostic model

The kiosk is designed to run more than 30 tests, combining invasive and non-invasive services. Its AI diagnostic engine currently operates at an efficiency rate of more than 90 per cent, according to the company, which expects performance to improve as it collects more data and continues clinical refinement.

Tests currently highlighted include ECG monitoring, SpO2 assessment and other vital signs. The model is based on earlier detection of health issues through community-based screening, followed by remote consultation and further care if needed.

It is intended to reduce dependence on large urban hospitals for initial assessments. In practice, MediElaj aims to create a pathway in which a patient receives an initial screening locally, reviews the result through the app and then connects with a clinician without travelling outside the district.

Regulatory steps

MediElaj says it holds ISO 13485 and ISO 14791 certifications and has secured test and commercial licences for Indian operations under the Software as a Medical Device framework. It also says it complies with the Digital Personal Data Protection Act and other relevant quality and privacy standards.

The company has signed memorandums of understanding with hospitals and medical colleges to support collaborative research. It is also in discussions with the governments of two western Indian states over possible healthcare pilots, subject to clinical validation.

Such steps are significant for health technology groups working with diagnostic software, where scrutiny over reliability and patient safety is high. Companies in this sector often face questions from clinicians, regulators and public health bodies about the evidence behind AI-led decision tools.

Expansion plans

MediElaj is preparing to expand beyond India, with Dubai and the United Kingdom identified as priority markets as it works on compliance with international healthcare, quality and privacy rules.

The company is betting that a kiosk-and-app structure will be easier to replicate than building a network of physical clinics. Each kiosk can be installed in an existing community setting, while the software platform can add users independently of the hardware footprint.

The Gurugram site now serves as the first test of whether that model can gain regular use in a local setting. More than 200 diagnoses from one machine in one location provide an early operational benchmark as MediElaj seeks validation for a broader rollout across underserved communities in India and, later, overseas.